Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$456M |
| 2 |
SW
Smurfit Westrock
SW
|
+$403M |
| 3 |
Walt Disney
DIS
|
+$391M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$345M |
| 5 |
EPAM Systems
EPAM
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$671M |
| 2 |
Nike
NKE
|
+$557M |
| 3 |
Microchip Technology
MCHP
|
+$544M |
| 4 |
Visa
V
|
+$535M |
| 5 |
Becton Dickinson
BDX
|
+$487M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.06% |
| 2 | Financials | 10.52% |
| 3 | Healthcare | 9.63% |
| 4 | Industrials | 8.45% |
| 5 | Consumer Discretionary | 7.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Columbia Seligman Semiconductor and Technology ETF
SEMI
$38.8M
| $16.5M | ﹤0.01% |
640,850
| – | – |
|
1427
Primoris Services
PRIM
$4.45B
| $16.4M | ﹤0.01% |
282,750
+12,896
| +5% | +$688K |
|
1428
Laureate Education
LAUR
$5.28B
| $16.4M | ﹤0.01% |
986,268
+178,371
| +22% | +$2.73M |
|
1429
Rio Tinto
RIO
$164B
| $16.4M | ﹤0.01% |
229,963
-148
| -0.1% | -$9.51K |
|
1430
Krystal Biotech
KRYS
$9.66B
| $16.3M | ﹤0.01% |
89,749
-12,247
| -12% | -$2.36M |
|
1431
M/I Homes
MHO
$3.84B
| $16.3M | ﹤0.01% |
95,197
-11,194
| -11% | -$1.7M |
|
1432
FirstCash
FCFS
$8.78B
| $16.3M | ﹤0.01% |
142,024
+103,414
| +268% | +$11.7M |
|
1433
Extreme Networks
EXTR
$3.15B
| $16.3M | ﹤0.01% |
1,083,883
+68,189
| +7% | +$966K |
|
1434
Ally Financial
ALLY
$13.3B
| $16.3M | ﹤0.01% |
457,190
+21,205
| +5% | +$848K |
|
1435
Carter's
CRI
$1.47B
| $16.2M | ﹤0.01% |
249,862
-30,600
| -11% | -$1.97M |
|
1436
Lincoln Electric
LECO
$15.4B
| $16.2M | ﹤0.01% |
84,320
+4,461
| +6% | +$856K |
|
1437
JPMorgan Municipal ETF
JMUB
$8.47B
| $16.2M | ﹤0.01% |
316,146
+222,318
| +237% | +$11.3M |
|
1438
Piper Sandler
PIPR
$5.29B
| $16.1M | ﹤0.01% |
227,124
-12,972
| -5% | -$848K |
|
1439
First Citizens BancShares
FCNCA
$25.3B
| $16.1M | ﹤0.01% |
8,727
-5,840
| -40% | -$11.1M |
|
1440
Perella Weinberg Partners
PWP
$1.3B
| $16.1M | ﹤0.01% |
831,429
+668,828
| +411% | +$12.3M |
|
1441
Flex
FLEX
$44.8B
| $16M | ﹤0.01% |
478,932
+32,505
| +7% | +$1,000K |
|
1442
N-able
NABL
$940M
| $16M | ﹤0.01% |
1,225,317
-123,952
| -9% | -$1.66M |
|
1443
Ionis Pharmaceuticals
IONS
$9.4B
| $15.9M | ﹤0.01% |
397,898
+389,106
| +4,426% | +$18.1M |
|
1444
Phillips Edison & Co
PECO
$5.24B
| $15.9M | ﹤0.01% |
422,023
+90,971
| +27% | +$3.25M |
|
1445
Sabra Healthcare REIT
SBRA
$5.37B
| $15.9M | ﹤0.01% |
853,291
+482,818
| +130% | +$8.14M |
|
1446
Tronox
TROX
$1.04B
| $15.9M | ﹤0.01% |
1,085,381
+140,745
| +15% | +$2.01M |
|
1447
First Trust Natural Gas ETF
FCG
$623M
| $15.9M | ﹤0.01% |
668,415
+382,417
| +134% | +$9.61M |
|
1448
Newell Brands
NWL
$2.56B
| $15.9M | ﹤0.01% |
2,065,320
+28,834
| +1% | +$207K |
|
1449
Belden
BDC
$5.19B
| $15.8M | ﹤0.01% |
135,179
-86,751
| -39% | -$8.7M |
|
|
JHG
1450
DELISTED
Janus Henderson
JHG
| $15.8M | ﹤0.01% |
415,231
+32,355
| +8% | +$1.17M |
|
Similar funds
Ameriprise's Q3 2024 Portfolio in Review
As of Q3 2024, Ameriprise held 4,064 positions worth $390B, up 5.5% from $370B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ameriprise's Q3 2024 filing shows 197 new, 1,617 increased, 1,938 reduced and 141 closed positions. Its largest new stake was Smurfit Westrock: 8,854,270 shares worth $438M. The largest sale was Apple, an estimated $671M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q3 2024 buy was Smurfit Westrock: 8,854,270 shares worth $438M.
- Ameriprise added most to UnitedHealth in Q3 2024, an estimated $456M increase.
- Ameriprise's biggest Q3 2024 reduction was Apple, cutting an estimated $671M.
- Ameriprise fully exited Cerevel Therapeutics Holdings, Inc. Common Stock in Q3 2024, selling an estimated $55.1M.
- Ameriprise's ten largest holdings make up 19% of its $390B portfolio in Q3 2024.
- Ameriprise opened 197 new positions and closed 141 in Q3 2024.
- Ameriprise's portfolio value rose 5.5% quarter-over-quarter to $390B.
Based on Ameriprise's 13F filing for Q3 2024, filed 14 Nov 2024.